Abstract
Pyrrolo[1,4]benzodiazepines (PBDs) are a growing group of microbial secondary metabolites that showed remarkable biological activities particularly against tumor cells. Their antitumor activity is mainly due to their specifically binding to DNA and other polydeoxynucleotides to form irreversibly polymer-bound drugs. Consequently, they have been the target of several syntheses as well as screening of natural sources to discover new members. This review provides an update on recent discoveries of PBDs as well as a compilation of spectroscopic data described in the literature.
Keywords: Pyrrolo[1,4]benzodiazepines (PBDs), biological activity, natural products
Mini-Reviews in Organic Chemistry
Title: Naturally Occuring Pyrrolo[1,4]benzodiazepines in Bacteria
Volume: 7 Issue: 1
Author(s): Serge Fotso
Affiliation:
Keywords: Pyrrolo[1,4]benzodiazepines (PBDs), biological activity, natural products
Abstract: Pyrrolo[1,4]benzodiazepines (PBDs) are a growing group of microbial secondary metabolites that showed remarkable biological activities particularly against tumor cells. Their antitumor activity is mainly due to their specifically binding to DNA and other polydeoxynucleotides to form irreversibly polymer-bound drugs. Consequently, they have been the target of several syntheses as well as screening of natural sources to discover new members. This review provides an update on recent discoveries of PBDs as well as a compilation of spectroscopic data described in the literature.
Export Options
About this article
Cite this article as:
Fotso Serge, Naturally Occuring Pyrrolo[1,4]benzodiazepines in Bacteria, Mini-Reviews in Organic Chemistry 2010; 7 (1) . https://dx.doi.org/10.2174/1570193X11007010068
DOI https://dx.doi.org/10.2174/1570193X11007010068 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Chemical Metabolic Inhibitors for the Treatment of Blood-Borne Cancers
Anti-Cancer Agents in Medicinal Chemistry Seek and Destroy: The Use of Natural Compounds for Targeting the Molecular Roots of Cancer
Current Drug Targets Topoisomerase II Inhibitors and Poisons, and the Influence of Cell Cycle Checkpoints
Current Medicinal Chemistry 9-Hydroxyellipticine and Derivatives as Chemotherapy Agents
Mini-Reviews in Medicinal Chemistry Identifying Molecular Targets Mediating the Anticancer Activity of Histone Deacetylase Inhibitors: A Work in Progress
Current Cancer Drug Targets Herpes Simplex Virus Vectors for the Nervous System
Current Gene Therapy Recent Advances and Developments in Treatment Strategies Against Pancreatic Cancer
Current Clinical Pharmacology Transposons for Gene Therapy!
Current Gene Therapy Molecular Pharmacology of Malignant Pleural Mesothelioma: Challenges and Perspectives From Preclinical and Clinical Studies
Current Drug Targets Kaempferol-3-<i>O</i>-Rhamnoside Inhibits the Proliferation of Jurkat Cells Through Jun Amino-Terminal Kinase Signaling
The Natural Products Journal Insights into the Role of Fc Gamma Receptors (FcγRs) Genetic Variations in Monoclonal Antibody-Based Anti-Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Noxa: Role in Cancer Pathogenesis and Treatment
Current Cancer Drug Targets Inhibition of DNA Polymerase λ Suppresses 12-O-Tetradecanoylphorbol- 13-Acetate-Induced Inflammation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents The Involvement of Heat Shock Proteins and Related Molecules in the Resistance to Therapies in Breast and Gynecologic Cancer
Current Cancer Therapy Reviews MDM2-p53 Interaction in Paediatric Solid Tumours: Preclinical Rationale, Biomarkers and Resistance
Current Drug Targets Embryonic Morphogenetic Field Induces Phenotypic Reversion in Cancer Cells. Review Article
Current Pharmaceutical Biotechnology Nucleic Acid-Based Aptamers: Applications, Development and Clinical Trials
Current Medicinal Chemistry CD45 Regulated Signaling Pathways
Current Topics in Medicinal Chemistry Clinical Immunotherapy of B-Cell Malignancy Using CD19-Targeted CAR T-Cells
Current Gene Therapy Protein Kinases as Drug Targets in Human and Animal Diseases
Current Enzyme Inhibition